M, M., R, A. F., M, O., M, B., E, T., S, E., . . . I, M. (2024). Influence of cytochrome P450 2D6*10/*10 genotype on the risk for tramadol associated adverse effects: A retrospective cohort study. Frontiers in pharmacology, 15, 1358549. https://doi.org/10.3389/fphar.2024.1358549
Chicago Style (17th ed.) CitationM, Mahajna, Abu Fanne R, Odeh M, Berkovitch M, Tannous E, Eyal S, Vinker S, Green I, and Matok I. "Influence of Cytochrome P450 2D6*10/*10 Genotype on the Risk for Tramadol Associated Adverse Effects: A Retrospective Cohort Study." Frontiers in Pharmacology 15 (2024): 1358549. https://doi.org/10.3389/fphar.2024.1358549.
MLA (9th ed.) CitationM, Mahajna, et al. "Influence of Cytochrome P450 2D6*10/*10 Genotype on the Risk for Tramadol Associated Adverse Effects: A Retrospective Cohort Study." Frontiers in Pharmacology, vol. 15, 2024, p. 1358549, https://doi.org/10.3389/fphar.2024.1358549.